These results are consistent with a recent study of cycloastragenol on IMQ-induced psoriasis-like skin lesions, which regulate macrophage via inhibiting NLRP3 inflammasome-mediated pyroptosis (Deng et al., 2019). This evidence concerns the gene NLRP3 and psoriasis.